AURORA S K ET AL: "OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.", CEPHALALGIA : AN INTERNATIONAL JOURNAL OF HEADACHE JUL 2010 LNKD- PUBMED:20647170, vol. 30, no. 7, July 2010 (2010-07), pages 793-803, XP9149743, ISSN: 1468-2982 (B1)

BLUMENFELD ANDREW ET AL: "Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.", HEADACHE OCT 2010 LNKD- DOI:10.1111/J.1526-4610.2010.01766.X PUBMED:20958294, vol. 50, no. 9, October 2010 (2010-10), pages 1406-1418, XP002646357, ISSN: 1526-4610 (B1)

US-A1- 2010 266 638 (B1)

MATHEW NINAN T ET AL: "Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.", HEADACHE APR 2005 LNKD- PUBMED:15836565, vol. 45, no. 4, April 2005 (2005-04), pages 293-307, XP002646358, ISSN: 0017-8748 (B1)

SILBERSTEIN STEPHEN D ET AL: "Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.", MAYO CLINIC PROCEEDINGS. MAYO CLINIC SEP 2005 LNKD- PUBMED:16178492, vol. 80, no. 9, September 2005 (2005-09), pages 1126-1137, XP002646359, ISSN: 0025-6196 (B1)

DIENER H C ET AL: "OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.", CEPHALALGIA : AN INTERNATIONAL JOURNAL OF HEADACHE JUL 2010 LNKD- PUBMED:20647171, vol. 30, no. 7, July 2010 (2010-07), pages 804-814, XP9149742, ISSN: 1468-2982 (B1)